Impact of Suramin on Key Pathological Features of Sporadic Alzheimer’s Disease-Derived Forebrain Neurons
Journal of Alzheimer’s Disease · 2024
DOI: 10.3233/jad-230600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Robert A Culibrk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 122 Literaturangaben. Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) is characterized by disrupted proteostasis and macroautophagy (hereafter “autophagy”). The pharmacological agent suramin has known autophagy modulation properties with potential efficacy in mitigating AD neuronal pathology.
Objective
In the present work, we investigate the impact of forebrain neuron exposure to suramin on the Akt/mTOR signaling pathway, a major regulator of autophagy, in comparison with rapamycin and chloroquine. We further investigate the effect of suramin on several AD-related biomarkers in sporadic AD (sAD)-derived forebrain neurons.
Methods
Neurons differentiated from ReNcell neural progenitors were used to assess the impact of suramin on the Akt/mTOR signaling pathway relative to the autophagy inducer rapamycin and autophagy inhibitor chloroquine. Mature forebrain neurons were differentiated from induced pluripotent stem cells (iPSCs) sourced from a late-onset sAD patient and treated with 100μM suramin for 72 h, followed by assessments for amyloid-β, phosphorylated tau, oxidative/nitrosative stress, and synaptic puncta density.
Results
Suramin treatment of sAD-derived neurons partially ameliorated the increased p-Tau(S199)/Tau ratio, and fully remediated the increased glutathione to oxidized nitric oxide ratio, observed in untreated sAD-derived neurons relative to healthy controls. These positive results may be due in part to the distinct increases in Akt/mTOR pathway mediator p-p70S6K noted with suramin treatment of both ReNcell-derived and iPSC-derived neurons. Longer term neuronal markers, such as synaptic puncta density, were unaffected by suramin treatment.
Conclusions
These findings provide initial evidence supporting the potential of suramin to reduce the degree of dysregulation in sAD-derived forebrain neurons in part via the modulation of autophagy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA.
- Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, USA.
Förderung
- NIA NIH HHS
Zitieren
APA
Culibrk, R. A., Ebbert, K. A., Yeisley, D. J., Chen, R., Qureshi, F. A., Hahn, J., & Hahn, M. S. (2024). Impact of Suramin on Key Pathological Features of Sporadic Alzheimer’s Disease-Derived Forebrain Neurons. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-230600
Vancouver
Culibrk RA, Ebbert KA, Yeisley DJ, Chen R, Qureshi FA, Hahn J, et al. Impact of Suramin on Key Pathological Features of Sporadic Alzheimer’s Disease-Derived Forebrain Neurons. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-230600
BibTeX
@article{Culibrk2024,
author = {Culibrk, Robert A and Ebbert, Katherine A and Yeisley, Daniel J and Chen, Rui and Qureshi, Fatir A and Hahn, Juergen and Hahn, Mariah S},
title = {Impact of Suramin on Key Pathological Features of Sporadic Alzheimer’s Disease-Derived Forebrain Neurons},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
doi = {10.3233/jad-230600}
}
EUVIMED